Yuyu Pharma Inc (000225) - Total Liabilities

Latest as of March 2026: ₩64.72 Billion KRW ≈ $43.86 Million USD

Based on the latest financial reports, Yuyu Pharma Inc (000225) has total liabilities worth ₩64.72 Billion KRW (≈ $43.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Yuyu Pharma Inc growing its equity to track the company's year-over-year net asset growth rate.

Yuyu Pharma Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Yuyu Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Yuyu Pharma Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Yuyu Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Bina Darulaman Bhd KLSE:6173	Malaysia	RM352.44 Million
MSCM Holdings Bhd KLSE:0041	Malaysia	RM78.65 Million
Euromedis Groupe SA PA:ALEMG	France	€23.04 Million
TCS Group Holdings Bhd KLSE:0221	Malaysia	RM197.29 Million
Gigasun AB ST:GIGA	Sweden	Skr1.81 Billion
First Media Tbk JK:KBLV	Indonesia	Rp1.44 Trillion
Xintela AB ST:XINT	Sweden	Skr36.95 Million
BALAXI PHARMACEUTICALS LIMITED NSE:BALAXI	India	Rs844.30 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Yuyu Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuyu Pharma Inc (000225) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma Inc (2014–2025)

The table below shows the annual total liabilities of Yuyu Pharma Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩66.68 Billion ≈ $45.19 Million	-8.19%
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	--

About Yuyu Pharma Inc

KO:000225 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$14.10 Million

₩20.80 Billion KRW

Market Cap Rank

#26165 Global

#1962 in Korea

Share Price

₩3550.00

Change (1 day)

+1.57%

52-Week Range

₩3375.00 - ₩5250.00

All Time High

₩25149.31